Jared Aarons, ABC 10 News San Diego, June 3, 2021
A study looking at cannabis as a potential treatment for acute migraines is being conducted by Dr. Nathaniel Schuster.
Click here to read the full article and how to enroll
Michelle Brubaker, UC San Diego Health Newsroom, May 19, 2021
Dr. Nathaniel Schuster is conducting the first known randomized, double-blind, placebo controlled clinical trial looking at cannabis as a potentially effective treatment for acute migraines.
Click here to read the full article and how to enroll
Findings suggest CBD may be used as a strategy to alleviate the withdrawal symptoms upon nicotine cessation.
In November 2020, the California Bureau of Cannabis Control (BCC) announced the recipients for its public university research grants program. The BCC received more than 100 applications from public universities across California. Research proposals had to fall within one of the several specified categories which included public health, criminal justice and public safety, economic, environmental impacts, and the cannabis industry. Below are the projects by UC San Diego researchers that received funding.
| Principal Investigator | Research proposal title | Awarded funding |
| Hill, Linda | The Public Health Impact of Cannabis Legalization in California: A Comprehensive Qualitative and Quantitative Analysis by Age, Gender, Race/Ethnicity, and Regions | $1,321,833 |
| Shi, Yuyan | Evaluating the Impacts of Packaging and Labeling on Cannabis Edible Use among Youth | $987,738 |
| Morgan, Erin | The Role of Cannabidiol in Anandamide-Related Improvement in Alexithymia and Health Outcomes | $887,101 |
| Han, Benjamin | Evaluating Risks and Benefits of Cannabis Use by Older Adults: A Pilot | $235,039 |
Congratulations to UC San Diego cannabis researchers on the success of their applications!
John Watson, Medscape, January 5, 2021
Dr. Mark Wallace spoke to Medscape about cannabis treatment for pain management and other current cannabis research taking place at CMCR and UC San Diego.
Page 14 of 23